Dexmedetomidine verus fentanyl as adjuvants to scalp block in patients undergoing elective craniotomy

Dexmedetomidine versus fentanyl as adjuvants to scalp block in patients undergoing elective craniotomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201608001745312

Enrollment

Registered

2016-08-19

Start date

2016-06-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery anesthesia and postoperative pain

Interventions

Group I: Control group ( C ):

Fentanyl scalp block group ( F ):

Dexmedetomidine scalp block group ( D):

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 18 ¿ 60 years either gender ASA I-III undergoing elective supratentorial craniotomy

Exclusion criteria

Exclusion criteria: includes patient refusal inability to understand and incapacity to use VAS score allergy to studied drugs significant pathology at the sites of infiltration patients who were chosen for elective postoperative ventilation and post-inclusion postoperative ventilation.

Design outcomes

Primary

Measure	Time frame
VAS;¿Duration of analgesia	—

Secondary

Measure	Time frame
¿ HR and MAP ;¿ Time of first analgesic request.;¿ Total intraoperative fentanyl consumption.;Total consumption of rescue analgesia ;Postoperative sedation ;complications;patient satisfaction	—

Countries

Egypt

Contacts

Public ContactShaimaa Farouk

lecturer of anesthesia and ICU, Faculty of medicine, Tanta University

Shaimaafarouk7777@yahoo.com01270440771

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026